Estimates Revisions Takeda Pharmaceutical Company Limited NYSE
Stocks
TAK
US8740602052
Pharmaceuticals
|
Market Closed -
NYSE
01:30:02 02/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 18.23 USD | +1.39% |
|
-0.05% | +16.93% |
| 01/09 | Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House | MT |
| 31/08 | Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
- Consensus Takeda Pharmaceutical Company Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
